Ridgewood Investments LLC Increases Position in McKesson Co. (MCK)

Ridgewood Investments LLC increased its position in McKesson Co. (NYSE:MCK) by 37.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,584 shares of the company’s stock after purchasing an additional 702 shares during the quarter. Ridgewood Investments LLC’s holdings in McKesson were worth $302,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Proficio Capital Partners LLC boosted its holdings in McKesson by 161.2% during the fourth quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock worth $25,000 after buying an additional 137 shares during the last quarter. Bedel Financial Consulting Inc. lifted its holdings in shares of McKesson by 165.2% during the 4th quarter. Bedel Financial Consulting Inc. now owns 236 shares of the company’s stock valued at $26,000 after purchasing an additional 147 shares in the last quarter. Dubuque Bank & Trust Co. lifted its holdings in shares of McKesson by 106.7% during the 1st quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock valued at $40,000 after purchasing an additional 176 shares in the last quarter. Old North State Trust LLC lifted its holdings in shares of McKesson by 53.3% during the 4th quarter. Old North State Trust LLC now owns 391 shares of the company’s stock valued at $43,000 after purchasing an additional 136 shares in the last quarter. Finally, IMS Capital Management bought a new position in shares of McKesson during the 3rd quarter valued at about $57,000. Hedge funds and other institutional investors own 86.60% of the company’s stock.

MCK has been the topic of several recent analyst reports. Zacks Investment Research cut McKesson from a “hold” rating to a “sell” rating in a report on Thursday, January 3rd. ValuEngine cut McKesson from a “sell” rating to a “strong sell” rating in a report on Saturday, January 5th. Barclays reiterated a “hold” rating and set a $124.00 price objective on shares of McKesson in a report on Sunday, January 6th. UBS Group initiated coverage on McKesson in a report on Thursday, January 17th. They set a “neutral” rating and a $134.00 price objective on the stock. Finally, Deutsche Bank upgraded McKesson from a “sell” rating to a “hold” rating and set a $175.00 price objective on the stock in a report on Friday, January 25th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the stock. McKesson currently has an average rating of “Hold” and a consensus price target of $134.90.

In other McKesson news, EVP Lori A. Schechter sold 7,700 shares of the business’s stock in a transaction that occurred on Wednesday, January 16th. The stock was sold at an average price of $122.96, for a total transaction of $946,792.00. Following the transaction, the executive vice president now owns 10,000 shares of the company’s stock, valued at approximately $1,229,600. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.87% of the stock is owned by insiders.

Shares of McKesson stock opened at $117.21 on Tuesday. McKesson Co. has a 52-week low of $106.11 and a 52-week high of $160.84. The company has a market capitalization of $22.48 billion, a P/E ratio of 9.29, a PEG ratio of 1.17 and a beta of 1.24. The company has a current ratio of 1.02, a quick ratio of 0.57 and a debt-to-equity ratio of 0.81.

McKesson (NYSE:MCK) last announced its earnings results on Thursday, January 31st. The company reported $3.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.18 by $0.22. McKesson had a positive return on equity of 27.83% and a negative net margin of 0.15%. The business had revenue of $56.21 billion for the quarter, compared to analyst estimates of $55.27 billion. During the same quarter last year, the firm earned $3.41 EPS. Research analysts forecast that McKesson Co. will post 13.55 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Friday, March 1st were given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend was Thursday, February 28th. McKesson’s dividend payout ratio (DPR) is 12.36%.

TRADEMARK VIOLATION NOTICE: This article was published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.com-unik.info/2019/04/16/ridgewood-investments-llc-increases-position-in-mckesson-co-mck.html.

About McKesson

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Featured Story: Cost of Debt

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit